Applications are invited on plain paper with details of qualifications, experience, contacts and two letter of reference for
JRF
/SRF positions in Interdisciplinary Program in
Life Science
(now BUILDER programme sponsored by
DBT
, Govt. of India. The program is primarily focused on drug discovery through interdisciplinary research. Interested candidates may send their application to Prof. P. P. Mathur, Coordinator, Interdisciplinary Program in
Life Science
, Pondicherry University, Puducherry-605014.
Post : Junior Research Fellows (09
- Minimum qualifications :
M.Sc
. in any branch of
Life Sciences
/ Pharmacology/ Chemical Sciences or
M.Tech
candidates in any branch of
Life Sciences
with a minimum of 55% marks.
Post : Senior Research Fellows (03
- Minimum qualifications :
M.Sc
in any branch of
Life Sciences
/ Pharmacology/ Chemical Sciences with a minimum of 55% marks or
M.Tech
in any branch of
Life Science
with a minimum of 55% marks with two years of research experience as evidenced by published papers in standard refereed journals.
Age Limit : 28 years for
JRF
and 32 years for SRF. Age relaxation as per Government norms.
Emoluments :
- Rs 16, 000/- for
JRF
+ HRA as per University norms.
- Rs 18,000/- for SRF per month + HRA as per University norms.
Mode of Selection :
- Short listed candidates will be selected based on their performance in the written examination followed by interview to be conducted at Pondicherry University.
Registration for
PhD
: Candidates selected for
JRF
and SRF may register for
PhD
programme in Pondicherry University as per university regulations.
Last date for applying is 12.03.2012
Certain leukaemia drug treatments might stop the Ebola virus developing in the body, according to new US research unveiled on 29 February 2012.
Fatal in all but 10 per cent of cases, Ebola was first identified in Africa around four decades ago. It's comparatively rare but, even so, has come to be regarded as a highly dangerous condition.
However, two leukaemia treatments drugs - imatinib and nilotinib - seem to be able to prevent reproduction of the Ebola virus, according to data released by the US National Institute of Allergy and Infectious Diseases and subsequently published by Science Translational Medicine.
Leukaemia Drug Ebola Treatment
The leukaemia drug Ebola treatment findings followed lab-based trials involving embryonic kidney cells, which revealed that the c-Abl1 tyrosine kinase protein was instrumental in the virus replication process. By putting the brakes on this protein's activity, the researchers were able to stop the Ebola from spreading.
Alongside this, the leukaemia drugs also prevented the Ebola-infected cells from releasing viral particles - a mechanism called ‘filovirus budding'.
‘Drugs that target filovirus budding would be expected to reduce the spread of infection, giving the immune system time to control the infection', the US National Institute of Allergy and Infectious Disease representatives explained in their report, adding: ‘Our results suggest that short-term administration of nilotinib or imatinib may be useful in treating Ebola virus infections.'
Ebola Virus Treatment Study
Imatinib has several trade names including Glivec and Gleevec and it's prescribed to chronic myelogenous leukaemia patients, while nilotinib, which is marketed as Tasigna, treats the same condition but in cases where imatinib hasn't helped.
Referring to both drugs, the Ebola virus treatment study's authors described their ‘safety profiles' as ‘reasonable' but added: ‘some cardiac toxicity has been reported with long-term administration in a small number of patients.'
Data release by WHO (the World Health Organization reveals that, over the past 36 years, there's been 1,200 fatal cases of Ebola recorded around the world.
At the very end of 2011, Pharma International reported on the development of a
long-lasting effective Ebola vaccine. Prior to that, we covered
MIT's DRACO drug - a product with the potential to kill almost every virus known to man, Ebola included.
Image copyright Public Library of Science - Courtesy Wikimedia Commons
North Eastern Region
Biotechnology
Progeamme Management Cell (NER-BPMC
NER-BPMC has been set up by the Department of
Biotechnology
, Ministry of Science & Technology, Government of India through Biotech Consortium India Limited (BCIL for development, coordination and monitoring of
Biotechnology
programmes in the North Eastern States of India. Applications under NER-BPMC are invited for the posts of four Senior consultants one each in the area of Healthcare / Medical
Biotechnology
,
Agriculture
, Animal Sciences / Livestocks, HRD.
Post : Senior Consultant
- No of Posts : Four
- Stream : Healthcare / Medical
Biotechnology
,
Agriculture
, Animal Sciences / Livestocks
- Essential Qualification : Candidates having master's degree in the respective areas ie
Life Sciences
,
Biotechnology
, Pharma,
Agriculture
, Animal Sciences, Livestocks from a recognized Unversity with a minimum of 10 years of relevant experience in the respective areas preferably in implementing major research programmes.
- Desirable : Candidates having
PhD
in respective areas with experience in handling projects in North Eastern Region of India and recently superannuated would be preferred.
- Emoluments : Rs 60000/- pm with conveyance allowance of Rs 30000/- pm
The above full time consultancy assignments are contractual for a period of aone year with a scope of further extension. Please apply latest by 12th March 2012 with detailed resume (Soft copy only strictly in the format given at
www.bcil.nic.in by email to :
The Managing Director
Biotech Consortium India Limited (BCIL
Anuvrat Bhawan, 5th Floor, 210
Deen Dayal Upadhyaya Marg
New
Delhi
- 110002
Tel : 011-23219064; Fax : 011-23219063
Email :
career@biotech.co.in
Deadline : 12.03.12
Traditionally, depression researchers have sought to identify the individual brain areas responsible for causing these symptoms. But the combination of so many symptoms suggested to UCLA researchers that the multiple symptoms of depression may be linked to a malfunction involving brain networks — the connections that link different brain regions.
Now, for the first time, these UCLA researchers have shown that people with depression have increased connections among most brain areas. Indeed, their brains are widely hyperconnected. The report, published this week in the online journal PLoS One, sheds new light on the brain dysfunction that causes depression and its wide array of symptoms.
"The brain must be able to regulate its connections to function properly," said the study's first author, Dr. Andrew Leuchter, a professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA. "The brain must be able to first synchronize, and then later desynchronize, different areas in order to react, regulate mood, learn and solve problems."
The depressed brain, Leuchter said, maintains its ability to form functional connections but loses the ability to turn these connections off.
"This inability to control how brain areas work together may help explain some of the symptoms in depression," he said.
In the study, the largest of its kind, the researchers studied the functional connections of the brain in 121 adults diagnosed with major depressive disorder, or MDD. They measured the synchronization of electrical signals from the brain — brain waves — to study networks among the different brain regions.
While some previous studies have hinted at abnormal patterns of connections in MDD, the UCLA team used a new method called "weighted network analysis" to examine overall brain connections. They found that the depressed subjects showed increased synchronization across all frequencies of electrical activity, indicating dysfunction in many different brain networks.
Brain rhythms in some of these networks regulate the release of serotonin and other brain chemicals that help control mood, said Leuchter, who is also the director of UCLA's Laboratory of Brain, Behavior, and Pharmacology and chair of the UCLA Academic Senate.
"The area of the brain that showed the greatest degree of abnormal connections was the prefrontal cortex, which is heavily involved in regulating mood and solving problems," he said. "When brain systems lose their flexibility in controlling connections, they may not be able to adapt to change.
"So an important question is, to what extent do abnormal rhythms drive the abnormal brain chemistry that we see in depression? We have known for some time that antidepressant medications alter the electrical rhythms of the brain at the same time that levels of brain chemicals like serotonin are changing. It is possible that a primary effect of antidepressant treatment is to 'repair' the brain's electrical connections and that normalizing brain connectivity is a key step in recovery from depression. That will be the next step in our research."
Other authors of the study include Dr. Ian A. Cook, Aimee M. Hunter, Chaochao Cai and Steve Horvath, all of UCLA. Funding for the study was provided by the National Institutes of Health, Lilly Research Laboratories and Pfizer Pharmaceuticals. The authors report no conflict of interest.
To learn more, visit www.brain.ucla.edu.
The Semel Institute for Neuroscience and Human Behavior is an interdisciplinary research and education institute devoted to the understanding of complex human behavior, including the genetic, biological, behavioral and sociocultural underpinnings of normal behavior, and the causes and consequences of neuropsychiatric disorders. In addition to conducting fundamental research, the institute's faculty seeks to develop effective strategies for the prevention and treatment of neurological, psychiatric and behavioral disorder, including improvement in access to mental health services and the shaping of national health policy.
For more news, visit the UCLA Newsroom and follow us on Twitter.
The institute offers an MSc in '
Bioinformatics
and
Biotechnology
'. The course will provide competence in both
Biotechnology
and computational biology/
Bioinformatics
by providing training in the areas of cell and
molecular biology
, computer science, statistics,
Bioinformatics
and so on (syllabus available below .
IBAB has been running a Postgraduate Diploma in
Bioinformatics
since 2002, and the 11th batch is currently doing its coursework. It has also been running a Postgraduate Diploma in Laboratory Biotechniques since 2004, and the 8th batch has completed its coursework. The two popular programmes are now being discontinued to enable the faculty to focus on the MSc programme.
Every student is provided
- Access to a fully loaded high-end PC and extensive access to the internet for the entire duration of 2 years.
- Lectures are delivered by in-house faculty, distinguished academics and industry scientists from leading institutions/companies within the country or from abroad.
- A significant amount of time is devoted to learning through material available on-line, journals, seminars, tutorials, group discussions etc.
- Thus the extensive lecture/tutorial program is supplemented by an enabling environment and associated self-learning through assignments and project work.
The 2 year MSc course is structured into 4 semesters, as below.
1. ADMISSION PROCEDURE
- Application processing fees (non-refundable
- Rs. 500/- for students from India and non-industrialized countries
- Rs. 1000/- for NRI/Foreign students from industrialized countries
- Rs. 500/- for students from India and non-industrialized countries
A Demand Draft for the above mentioned amount in favour of 'Institute of
Bioinformatics
and Applied
Biotechnology
' payable at Bengaluru needs to be sent to the institute (please see next section for other documents that also have to be submitted .
2. Application form
Fill up all details on-line and seprately send DD, 2 passport size photos and photocopies of marksheets to IBAB by post/courier. THIS IS THE ONLY OPTION FOR APPLYING. There is no hardcopy form available by downloading or by requesting a copy.
The online form will be processed only on receipt of the DD.
3. List of necessary documents
- Regular candidates:
- Photocopies of all certificates/marksheets
- NRI/Foreign candidates:
- Photocopies of all certificates/marksheets
- Proof of NRI/Foreign status (stamped page from passport
DO NOT send any original certificates/marksheets.
4. Important information:
a. Date of online test: To be announced later.
b. Date of Interview: You will be given a date between 16-19 July 2012. In case you have a problem with your allotted date, write to
msc2012@ibab.ac.in or call 080-285 289 00 or 01, 9611 872 946, 900 829 6547 between Monday and Friday from 10:00am to 5:30pm.
c. If a seat is offered, the last date for accepting it is 5 days after being intimated. At this time a token sum of Rs. 20,000/- (adjustable against the fees due at the time of joining has to be paid to the institute.
d. Course commences: 18 August 2012.
5. Eligibility for the course
a. A recognised BSc degree in any branch of science or technology, viz. life sciences (
Agriculture
,
Biotechnology
etc. , physics, chemistry, mathematics, statistics, engineering, pharma, veterinary or medicine with minimum of 55% marks. Thus, the following degree holders may apply: BSc, BTech, BE, MBBS, BDS, etc. Please contact IBAB in case you have a doubt about whether you are eligible.
b. Students awaiting their results can also apply, provided their average percentage of previous semesters/years is at least 55%.
c. There is no age limit.
Fees
Application processing fees (non-refundable :
1. Application processing fees (non-refundable :
Rs. 500/- for students from India or non-industrialized countries
Rs. 1000/- for NRI/Foreign students from industrialized countries
A DD for the above mentioned amount in favour of “Institute of
Bioinformatics
and Applied
Biotechnology
” payable at Bengaluru, should be sent to IBAB by post/courier or submitted in person after filling up the form online. Please note the other documents that also have to be submitted (2 passport photos and photocopies of marksheets .
2. Course fees per semester:
- For Indian students and students from non-industrialized countries.
- Academic fees: Rs. 50,000/- per semester. This includes tuition fees, laboratory fees, software fees and library fees. This has to be paid within a week of the joining date for each semester. In addition, there is a security deposit of Rs. 20,000/- (refundable only on completion of the course to be paid upon joining.
Please download the details and schedule of payment of course fees and hostel fees.
Partial waiver of fees through scholarships in case of a few deserving students may be feasible.
For NRI/Foreign students from industrialized countries
- Academic fees: Rs. 75,000/- per semester. This includes tuition fees, laboratory fees, software fees and library fees. This has to be paid within a week of the joining date for each semester. In addition, there is a security deposit of Rs. 30,000/- (refundable only on completion of the course to be paid upon joining.
Please download the details and schedule of payment of course fees and hostel fees.
Contact for further queries (between 10:00am and 5:30 pm, Mon-Fri : 080 - 285 289 00/01/02.
Mobile: 9611 872 946 / 900 829 6547
You can also send an email to
msc2012@ibab.ac.in
Syllabus
- The syllabus is liable to change over time. Please download the current syllabus from here.
No comments:
Post a Comment